Portal de investigación
TOX-IT: Identificación de biomarcadores predictivos de toxicidad en pacientes con melanoma en tratamiento con inmunoterapia.
Datos básicos
- Código:
- CIGE/2023/189
- Protocolo:
- CIGE/2023/189
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- 19.994,00 €
- Año de incio:
- 2024
- Año de finalización:
- 2025
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[[Translated article]]Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).
Couselo-Rodríguez C; (...); Flórez Á
Article. 10.1016/j.ad.2023.07.028. 2024
[[Translated article]]Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC).
Verdaguer-Faja, J.; (...); Carrascosa, J. M.
Article. 10.1016/j.ad.2024.04.013. 2024
[[Translated article]]Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
Sanchez-Diaz, M; (...); Carrascosa-Carrillo, J M
Article. 10.1016/j.ad.2024.01.019. 2024
[[Translated article]]RF-Personalized Medicine to Treat Atopic Dermatitis: In Search for Predictive Biomarkers.
Lasheras-Perez, M A, Navarro-Blanco, F, Rodriguez-Serna, M
Article. 10.1016/j.ad.2024.04.007. 2024
[Translated article] Fatal outcome in classic Kaposi's sarcoma.
Mansilla-Polo M, Botella-Estrada R
Article. 10.1016/j.ad.2024.03.015. 2024
[Translated article] Four-year Epidemiological Surveillance of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy: Current Situation and Trends.
Tous-Romero F; (...); Ortiz-de Frutos J
Article. 10.1016/j.ad.2024.02.006. 2024
[Translated article] RF-Longer Dupilumab Dosing Intervals in Atopic Dermatitis: Optimization or Therapeutic Failure?
Lasheras-Perez, M A, Navarro-Blanco, F, Rodriguez-Serna, M
Article. 10.1016/j.ad.2024.07.008. 2024
2-Hydroxyethyl methacrylate (2-HEMA) sensitization, a global epidemic at its peak in Spain?
Gatica-Ortega ME; (...); Borrego L
Article. 10.1111/cod.14520. 2024
A Case of Localised Immediate Hypersensitivity Reaction to Bimekizumab.
Lasheras-Perez, Miguel Antonio; (...); Ibanez-Echevarria, Ethel
Article. 10.1111/cod.14774. 2025
Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC).
Chicharro P; (...); Sánchez-Pérez J
Article. 10.1111/cod.14672. 2024
Atypical bullae in hands and trunk: An unusual suspect
Palacios-Diaz, Rodolfo David, Lasheras-Perez, Miguel Antonio, Rodriguez-Serna, Mercedes
Editorial Material. 10.1016/j.eimc.2023.12.010. 2024
Atypical bullae in hands and trunk: An unusual suspect.
Palacios-Diaz, Rodolfo David, Lasheras-Perez, Miguel Antonio, Rodriguez-Serna, Mercedes
Case Reports. 10.1016/j.eimce.2023.12.003. 2024
Correction: 'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.
Mansilla-Polo M; (...); Botella-Estrada R
Correction. 10.1007/s15010-024-02259-0. 2024
Characterizing Hepatitis Delta in Spain and the gaps in its management.
Rodriguez-Tajes, Sergio; (...); Lens, Sabela
Article. 10.1016/j.gastrohep.2024.502222. 2024
Chikungunya fever with a positive tourniquet test: a novel description.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1093/ced/llae089. 2024
Delusional parasitosis (Ekbom's syndrome).
Mansilla-Polo, M, Martin-Torregrosa, D, Botella-Estrada, R
Article. 10.1016/j.semerg.2024.102423. 2024
Dermatologic Consultations for Patients Hospitalized in Non-Dermatologic Wards: Results of a 384-Patient Cross-Sectional Study From a Tertiary Referral Hospital
Mansilla-Polo, M.; (...); Botella-Estrada, R.
Letter. 10.1016/j.ad.2024.10.030. 2024
Dermatological toxicities of talquetamab, a new bispecific antibody: case series and literature review.
Mansilla-Polo M; (...); Botella-Estrada R
Letter. 10.1111/ddg.15502. 2024
Dermatological toxicities of talquetamab, a new bispecificantibody: case series and literature review
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Letter. 10.1111/ddg.15502_g. 2024
Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study
Lasheras-Pérez MA; (...); Rodríguez-Serna M
Article. 10.1111/ijd.17030. 2024
Epidemiological, Clinical, and Allergic Profile of Psoriatic Patients. Evaluation of the Spanish Registry of Contact Dermatitis and Cutaneous Allergy (REIDAC).
Verdaguer-Faja J; (...); Carrascosa JM
Article. 10.1016/j.ad.2024.02.009. 2024
Erythema Elevatum Diutinum.
Mansilla-Polo M, Botella-Estrada R
Article. 10.1016/j.ad.2023.10.042. 2024
Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1016/j.abd.2024.04.004. 2024
Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence.
Verdaguer-Faja, Julia; (...); Jaka, Ane
Article. 10.1111/jdv.20250. 2024
Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma
Gutzmer, Ralf; (...); Hauschild, Axel
Article. 10.1186/s12885-024-13101-z. 2024
Interparietal nodule in a 49-year-old woman.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Case Reports. 10.1111/ddg.15398. 2024
Interparietaler Knoten bei einer 49-jährigen Frau
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15398_g. 2024
La eutanasia en el régimen penitenciario español.
Lasheras-Pérez MA; (...); Rodríguez-Serna M
Letter. 10.1016/j.semerg.2024.102219. 2024
'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1007/s15010-024-02214-z. 2024
Longer dupilumab dosing intervals in atopic dermatitis: optimization or therapeutic failure?
Lasheras-Pérez MA, Navarro-Blanco F, Rodríguez-Serna M
Article. 10.1016/j.ad.2023.04.043. 2024
Melanoma and LEOPARD Syndrome: Understanding the Role of PTPN11 Mutations in Melanomagenesis.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.2340/actadv.v104.14720. 2024
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).
Abril-Pérez C; (...); Botella-Estrada R
Article. 10.1111/jdv.20103. 2024
Nodular hidradenoma: Case report and brief literature review.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1016/j.patol.2025.100801. 2025
Oral Ruxolitinib could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series
Lasheras-Perez, M. A.; (...); Botella-Estrada, R.
Letter. 10.1016/j.ad.2023.07.035. 2025
Paraoxonase I Activity and Its Relationship with Nutrition in Amyotrophic Lateral Sclerosis.
Proaño B; (...); de la Rubia Ortí JE
Article. 10.3390/antiox13081021. 2024
Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023.
Pesqué D; (...); Giménez-Arnau AM
Article. 10.1111/cod.14702. 2024
Personalized medicine to treat atopic dermatitis: in search for predictive biomarkers.
Lasheras-Perez, M A, Navarro-Blanco, F, Rodriguez-Serna, M
Article. 10.1016/j.ad.2023.02.041. 2024
Pharmacogenetics of colorectal cancer in a third-level hospital in Valencia.
Comes-Raga A; (...); Herrero Cervera MJ
Article. 10.1515/almed-2024-0146. 2024
Polysensitization in the Spanish Contact Dermatitis Registry (REIDAC): A 2019-2022 prospective study with cluster and network analysis.
Pesque, David; (...); Gimenez-Arnau, Ana Maria
Article. 10.1111/jdv.19934. 2024
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1016/j.jhep.2024.07.035. 2024
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.
Ruiz-Cobo, Juan Carlos; (...); Buti, Maria
Article. 10.1111/apt.18020. 2024
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1111/ajd.14339. 2024
Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast
Mansilla-Polo, M.; (...); Botella-Estrada, R.
Letter. 10.1016/j.ad.2024.10.025. 2024
Recalcitrant lichen planopilaris treated with upadacitinib: a case series
Lasheras-Perez, Miguel A.; (...); Botella-Estrada, Rafael
Article. 10.1111/ijd.17339. 2024
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.
Gratacos-Gines, Jordi; (...); Pose, Elisa
Article. 10.1097/HEP.0000000000000825. 2024
Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series.
Martin-Torregrosa, Daniel; (...); Torres-Navarro, Ignacio
Letter. 10.1111/ijd.17022. 2024
Ruxolitinib for foreign body reaction to silicone in a patient with chronic graft-versus-host disease.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Letter. 10.1111/ijd.17365. 2024
Ruxolitinib oral puede aumentar la agresividad de los carcinomas escamosos cutáneos: serie de 6 pacientes.
Lasheras-Perez MA; (...); Botella-Estrada R
Article. 10.1016/j.ad.2024.10.003. 2025
Sarcoidosis cutánea tras inyecciones de plasma rico en plaquetas y maquillaje permanente de cejas.
Martín-Torregrosa D; (...); Botella-Estrada R
Article. 10.1016/j.ad.2024.10.043. 2024
Scaling and periorificial crusts in a pediatric patient.
Fayos-Gregori, Rafael; (...); Botella-Estrada, Rafael
Article. 10.1007/s15010-024-02309-7. 2024
Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022).
Hernández Fernández CP; (...); Doval IG
Article. 10.1111/cod.14513. 2024
Skin cancer risk after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1111/ijd.17371. 2024
Skin lesions in a lung transplant recipient
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Editorial Material. 10.1016/j.eimc.2023.09.005. 2024
Skin lesions in a lung transplant recipient.
Mansilla-Polo M; (...); Botella-Estrada R
Case Reports. 10.1016/j.eimce.2023.09.005. 2024
Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC)
Navarro-Trivino, F. J.; (...); Armario-Hita, J. C.
Article. 10.1016/j.ad.2024.05.018. 2024
Standard and Expanded Series Patch Testing Update by the Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
Navarro-Triviño FJ; (...); Carlos Armario-Hita J
Article. 10.1016/j.ad.2024.03.024. 2024
Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma
Diaz, Rodolfo David Palacios; (...); Estrada, Rafael Botella
Article. 10.1111/cup.14758. 2025
Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast.
Mansilla-Polo, Miguel; (...); Torres-Navarro, Ignacio
Letter. 10.1111/ijd.17293. 2024
Successful Treatment of Mogamulizumab-Associated Rash With Upadacitinib: Evidence From 2 Cases.
Martin-Torregrosa, Daniel; (...); Botella-Estrada, Rafael
Article. 10.1001/jamadermatol.2024.4582. 2024
Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1001/jamadermatol.2024.2160. 2024
Sustained response to anti-TNF therapy in ASIA syndrome triggered by vaccination and filler.
Martin-Torregrosa, Daniel; (...); Rodriguez-Serna, Mercedes
Letter. 10.1111/ijd.17650. 2025
Tattoo-Associated Common Wart
Mansilla-Polo, M., Llavador-Ros, M., Botella-Estrada, R.
Editorial Material. 10.1016/j.ad.2024.05.001. 2024
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study
Armario-Hita, Jose Carlos; (...); Ruiz-Villaverde, Ricardo
Article. 10.1111/ijd.17344. 2024
Treatment of palmoplantar psoriasis with oral roflumilast: a case series.
Lasheras-Perez, Miguel Antonio; (...); Botella-Estrada, Rafael
Article. 10.1093/ced/llae229. 2024
Use of an electrospun bioveil is safe and does not decrease skin graft take on burn wounds: A randomised, controlled clinical trial.
Perez-Del-Caz, Maria Dolores; (...); Perez-Plaza, Aranzazu
Article. 10.1016/j.burns.2025.107427. 2025